BXRX
Baudax Bio Inc
-52.79%
$3.41 - $1.61
Feb 7th 2023 - Mar 21st 2023
Nov, 29, 2022
$BXRX Even if they don't sell Anjeso, the prod... See more
Nov, 5, 2022
$EMED QB ticker announced new product , .01-.03 n... See more
TGTX
TG Therapeutics Inc
-19.05%
$18.43 - $14.92
Feb 7th 2023 - Mar 21st 2023
Feb, 27, 2023
I think that's a good number considering all t... See more
Feb, 27, 2023
Super excited for tomorrow's ER Guidance Call ... See more
BLUE
Bluebird bio Inc
-31.24%
$6.69 - $4.60
Feb 7th 2023 - Mar 21st 2023
Jan, 18, 2023
Now, disregarding product revenue, there is enough... See more
Oct, 24, 2022
Amazing company with great products.
Nov, 29, 2022
$BXRX Even if they don't sell Anjeso, the product is unique in a market with great potential.
Nov, 5, 2022
$EMED QB ticker announced new product , .01-.03 nice % incoming i believe
Oct, 11, 2022
$BXRX THE COMPANY HAS AN EXCELLENT PRODUCT MILOXICAM IV FOR PAIN RELIEF.
Oct, 7, 2022
A unique product on the market that will soon be marketed internationally as well.
Feb, 27, 2023
I think that's a good number considering all the work that goes into launching a product.
Feb, 27, 2023
Super excited for tomorrow's ER Guidance Call for our first ever FDA approved commercialized product, Briumvi!
Feb, 4, 2023
It’s not just the efficacy and safety of the product, it is the less cost for hospital/infusion, due to one hour infusion and the huge difference in price.
Jan, 4, 2023
Imagine how much Ubli could be worth to BP now with Briumvi’s best in class product profile.
Dec, 30, 2022
$TGTX This gonna be amazing guys after they sell their product Lets say 50.000 usd for the dose and they sell 500 a month Make the math and tell me how revenue they will get every quarter
Dec, 30, 2022
This is not some get rich scheme, this is a solid biotech company with an approved product that will bring in billions in revenue.